I Got My Game Back With
Fewer Asthma Attacks.
Bronchial Thermoplasty (BT) is proven to reduce severe asthma attacks out to at least 5 years1
Professional Basketball Player
2016 World Champion
Severe Asthma sufferer
Richard Jefferson is a BT patient and a paid spokesperson of the Alair™ System
See how BT works to reduce severe asthma attacks
BT is a minimally invasive outpatient procedure for adults with severe asthma.
It's a safe, clinically proven procedure delivered by the Alair™ System.2
patients share the dramatic difference Bronchial Thermoplasty has made in their lives.
79% of patients who were treated with BT reported a
significant improvement in their asthma-related quality of life2
How much does asthma impact your life?
Take the Free Asthma assessment Survey Now
Now Available On More Health Plans
Health plans across the U.S. cover Bronchial Thermoplasty (BT) and many more cover the procedure on a case-by-case basis.
Speak with a trained health care professional who can assist you in connecting with a BT-certified pulmonologist for an appointment.
Monday-Friday 9:00 AM — 8:00 PM Eastern
or Email BTcareconnect@bsci.com
Join theIt’s About Breathing Community
Learn how BT has helped people with severe asthma gain control of their asthma symptoms and improve their asthma-related quality of life.
The Alair™ Bronchial Thermoplasty System is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists.
As with any procedure, there are risks, and individual results may vary. The most common adverse event of BT is a temporary worsening of respiratory-related symptoms. These events typically occur within one day of the BT procedure and usually resolve within a week with standard care. There is a small risk (3.4% per procedure) that symptoms may require hospitalization.2
- Wechsler M et al. J Allergy Clin Immunol. 2013 Dec;132(6):1295-302.
- Castro M, et al, for the AIR2 Trial Study Group. Am J Respir Crit Care Med. 2010;181:116-124.